N-[(2S)-4-Methyl-1-oxo-1-{[(4S)-3-oxo-1-(2-pyridinylsulfonyl)-4-azepanyl]amino}-2-pentanyl]-1-benzofuran-2-carboxamide

N-[(2S)-4-Methyl-1-oxo-1-{[(4S)-3-oxo-1-(2-pyridinylsulfonyl)-4-azepanyl]amino}-2-pentanyl]-1-benzofuran-2-carboxamide is a synthetic small molecule with a molecular formula C26H30N4O6S and molecular weight of approximately 526.6 g/mol[5][3][1]. It is referenced in chemical and pharmacological databases as CHEMBL286364 and DrugBank DB03642. The compound has been studied as an experimental agent but is not approved for any therapeutic use[3]. It is structurally related to inhibitors of cathepsin proteases such as Cathepsin B, K, L, and S[5], suggesting its mechanism may involve inhibition of these cysteine proteases. These enzymes are implicated in various pathological processes including cancer metastasis and bone resorption; thus compounds targeting them are often explored for antineoplastic or antiresorptive indications. No clinical trials or approved indications are reported for this molecule[3].

Other names

(2S)-2-((1-benzofuran-2-yl)formamido)-4-methyl-N-((4S)-3-oxo-1-(pyridine-2-sulfonyl)azepan-4-yl)pentanamide(2S)-2-[(1-benzofuran-2-yl)formamido]-4-methyl-N-[(4S)-3‑oxo‑1‑(pyridine‑2‑sulfonyl)azepan‑4‑yl]pentanamideN‑((2S)–4-Methyl–1–oxo–1–(((4S)–3–oxo–1-(2-pyridinylsulfonyl)–4–azepanyl)amino)— — — — — — — (see PubChem synonyms)